Can Unisom (diphenhydramine or doxylamine) cause anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Unisom Cause Anxiety?

No, Unisom (diphenhydramine or doxylamine) does not typically cause anxiety as a direct effect; however, it can cause paradoxical CNS stimulation (particularly in children), and its anticholinergic side effects may produce agitation or restlessness that could be mistaken for anxiety. 1, 2

Understanding the Mechanism

Unisom contains either diphenhydramine or doxylamine, both first-generation antihistamines with anticholinergic and sedative properties 3. These medications work by blocking histamine H1-receptors and have central nervous system depressant effects, making them sedating rather than anxiety-provoking in most cases.

What the Evidence Shows

Sedation vs. Anxiety Effects

Research demonstrates that diphenhydramine primarily causes:

  • Sedation and drowsiness (the intended effect)
  • Fatigue and decreased motivation 4
  • Cognitive impairment rather than anxiety 4

In a comparative study, diphenhydramine was specifically distinguished from true anxiolytics (like alprazolam and pregabalin) because it did not increase calmness scores and produced different CNS effect profiles 5. This indicates diphenhydramine lacks anxiolytic properties but doesn't suggest it causes anxiety.

Mood Effects to Consider

Some antihistamines can negatively affect mood states. Studies show that cetirizine and hydroxyzine increased depression and anxiety subscale scores in patients 6, though this specific finding wasn't replicated for diphenhydramine or doxylamine in the available evidence.

Important Caveats and Paradoxical Reactions

Paradoxical CNS Stimulation

The FDA labels explicitly warn that "excitability may occur, especially in children" 2. This paradoxical stimulation could manifest as:

  • Restlessness
  • Agitation
  • Nervousness (which patients might describe as "anxiety")

Anticholinergic Side Effects

Both medications can cause anticholinergic effects that may mimic or trigger anxiety-like symptoms 3:

  • Dizziness
  • Blurred vision
  • Confusion (especially in overdose situations 7)
  • Urinary retention (which can cause distress)

Withdrawal and Rebound Effects

With chronic use, there is potential for:

  • Dependence (documented case reports exist 8)
  • Rebound insomnia upon discontinuation
  • Withdrawal symptoms that could include anxiety

Clinical Guideline Perspective

Guidelines explicitly recommend AGAINST using over-the-counter antihistamines for chronic insomnia due to "relative lack of efficacy and safety data" 9. The evidence for diphenhydramine shows:

  • Minimal clinically significant improvement in sleep parameters 10
  • No substantial benefit over placebo for most sleep outcomes 10
  • Potential for adverse effects including cognitive impairment 11, 12

Bottom Line for Clinical Practice

If a patient reports anxiety after taking Unisom:

  1. Consider alternative explanations first:

    • Paradoxical CNS stimulation (especially in children or elderly)
    • Anticholinergic side effects causing physical discomfort
    • Underlying anxiety disorder that the medication failed to address
    • Rebound effects if used chronically then discontinued
  2. Discontinue the medication - These agents are not recommended for chronic use anyway 9

  3. Screen for proper anxiety disorders - The patient may have an underlying anxiety condition requiring appropriate treatment 13

  4. Consider evidence-based alternatives:

    • For insomnia: Short-acting benzodiazepine receptor agonists or cognitive behavioral therapy 9
    • For anxiety: SSRIs, SNRIs, or appropriate anxiolytics 14, 13

The medication itself is fundamentally sedating, not anxiogenic, but individual reactions vary and chronic use is not recommended for multiple reasons 9, 10, 12.

References

Guideline

aga institute review of endoscopic sedation.

Gastroenterology, 2007

Research

Pharmacodynamic response profiles of anxiolytic and sedative drugs.

British journal of clinical pharmacology, 2017

Research

Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.

International journal of psychiatry in clinical practice, 2014

Research

Doxylamine Addiction: A Case Report.

Turk psikiyatri dergisi = Turkish journal of psychiatry, 2022

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.